Form 4: PROCEPT BioRobotics Corp: Director Acquires Shares and Options

Mary Garrett, a Director at PROCEPT BioRobotics Corp, acquired restricted stock units and a stock option, as detailed in a recent SEC Form 4 filing.

Summary

• Director Mary Garrett acquired 3,315 shares of Common Stock through restricted stock units (RSUs) on June 9, 2026.
• These RSUs vest in full on the one-year anniversary of the grant date or the next annual meeting, contingent on continued service.
• Garrett was also granted a stock option to purchase 5,853 shares of Common Stock on June 9, 2026, with an exercise price of $28.78.
• This stock option vests in full on the one-year anniversary of the grant date or the next annual meeting, also contingent on continued service.
• Following these transactions, Garrett beneficially owns 17,700 shares of Common Stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects standard executive compensation practices and director commitment rather than significant new financial performance or strategic shifts.

Positives

• Director Mary Garrett's acquisition of RSUs and stock options indicates a continued investment and commitment to the company.
• The grant of equity awards suggests a belief in the company's future performance and value appreciation.

Risks

• Vesting of RSUs and stock options is contingent on continued service, meaning forfeiture is possible if the individual leaves the company before the vesting date.
• The stock option has an exercise price of $28.78, implying that the stock price needs to exceed this level for the option to be profitable.

Future Outlook

The vesting schedules for the RSUs and stock option suggest a forward-looking perspective tied to continued service and company performance over the next year.

Industry Context

StockSavvy.ai notes that the issuance of equity awards like RSUs and stock options to directors is a common practice in the biotechnology sector to align management's interests with those of shareholders and incentivize long-term growth.

Stakeholder Impact

• Shareholders: The acquisition of equity by a director can be seen as a positive signal of confidence in the company's future prospects.
• Employees: Standard compensation practices for directors, unlikely to have a direct impact on other employees.
• Management: Reinforces alignment of interests between directors and the company through equity ownership.

Next Steps

• Vesting of RSUs and stock options on the specified dates, contingent on continued service.
• Potential exercise of stock options if the stock price exceeds the exercise price of $28.78.

Key Dates

Keywords

SEC Form 4, PROCEPT BioRobotics Corp, PRCT, Mary Garrett, Director, Restricted Stock Units, Stock Option, Beneficial Ownership, Equity Award